Maharashtra Herald

Sinusitis Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies – Optinose US Inc, GeneOne Life Science, Lyra Therapeutics

 Breaking News
  • No posts were found

Sinusitis Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies – Optinose US Inc, GeneOne Life Science, Lyra Therapeutics

September 30
14:30 2022
Sinusitis Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies - Optinose US Inc, GeneOne Life Science, Lyra Therapeutics
The Sinusitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Sinusitis pipeline products will significantly revolutionize the Sinusitis market dynamics.

DelveInsight’s Sinusitis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sinusitis, historical and forecasted epidemiology as well as the Sinusitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Sinusitis Overview

Sinusitis is one of the most common diagnoses in primary care. It causes substantial morbidity, often resulting in time off work, and is one of the commonest reasons why a general practitioner will prescribe antibiotics. The term sinusitis refers to inflammation of the mucosal lining of the paranasal sinuses. However, as sinusitis is invariably accompanied by inflammation of the adjacent nasal mucosa, a more accurate term is rhinosinusitis (RS).

 

Some of the key facts of the Sinusitis Market Report:  

  • The Sinusitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032) 
  • The study by Sedaghat et al., titled “Chronic Rhinosinusitis”, estimates that chronic rhinosinusitis is an inflammatory disease of the paranasal sinuses with a prevalence of 1–5% in the United States 
  • According to the study conducted by Yuan et al., titled “Chronic rhinosinusitis in Asia”, Chronic Rhinosinusitis (CRS)—an inflammatory condition of the nose and sinuses—is a common medical condition that affects about 11% of adults in Europe and about 12% of adults in the United States 
  • Key Sinusitis Companies: Optinose US Inc, GeneOne Life Science, Lyra Therapeutics, and others
  • Key Sinusitis Therapies: OPN-375, GLS-1200, LYR-220, and others 
  • The Sinusitis epidemiology based on gender analyzed that Chronic rhinosinusitis is approximately twice as common in females as compared to males 

 

Get a Free sample for the Sinusitis Market Report 

 

Key benefits of the Sinusitis Market report:

  1. Sinusitis market report covers a descriptive overview and comprehensive insight of the Sinusitis Epidemiology and Sinusitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Sinusitis market report provides insights on the current and emerging therapies.
  3. Sinusitis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Sinusitis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Sinusitis market.

 

Discover more about therapies set to grab major Sinusitis market share @ Sinusitis market forecast 

 

Sinusitis Epidemiology Segmentation:

The Sinusitis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Sinusitis
  • Prevalent Cases of Sinusitis by severity
  • Gender-specific Prevalence of Sinusitis
  • Diagnosed Cases of Episodic and Chronic Sinusitis 

 

Sinusitis Market  

The dynamics of the Sinusitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

Download the report to understand which factors are driving Sinusitis epidemiology trends @ Sinusitis Epidemiological Insights 

 

Sinusitis Market Drivers

  • Impairment of the skin barrier function carries the risks of wound formation, loss of immune function, and infection
  • Depending on the severity and location of chronic skin changes after RT, there is potential for decreased quality of life due to pain, recurrent wounds, decreased range of motion, and cosmetic dissatisfaction

 

Sinusitis Therapies and Key Companies

  • OPN-375: Optinose US Inc
  • GLS-1200: GeneOne Life Science
  • LYR-220: Lyra Therapeutics

 

Scope of the Sinusitis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Sinusitis Companies: Optinose US Inc, GeneOne Life Science, Lyra Therapeutics, and others
  • Key Sinusitis Therapies: OPN-375, GLS-1200, LYR-220, and others
  • Sinusitis Therapeutic Assessment: Sinusitis current marketed and Sinusitis emerging therapies
  • Sinusitis Market Dynamics:  Sinusitis market drivers and Sinusitis market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Sinusitis Unmet Needs, KOL’s views, Analyst’s views, Sinusitis Market Access and Reimbursement 

 

Sinusitis Market Unmet Needs

  • Challenges in Sinusitis diagnosis
  • Development of novel Sinusitis therapies
  • Limitations in gene therapy
  • Poor disease understanding
  • Clinical biomarkers 

 

Table of Contents 

1. Sinusitis Market Report Introduction

2. Executive Summary for Sinusitis

3. SWOT analysis of Sinusitis

4. Sinusitis Patient Share (%) Overview at a Glance

5. Sinusitis Market Overview at a Glance

6. Sinusitis Disease Background and Overview

7. Sinusitis Epidemiology and Patient Population

8. Country-Specific Patient Population of Sinusitis 

9. Sinusitis Current Treatment and Medical Practices

10. Sinusitis Unmet Needs

11. Sinusitis Emerging Therapies

12. Sinusitis Market Outlook

13. Country-Wise Sinusitis Market Analysis (2019–2032)

14. Sinusitis Market Access and Reimbursement of Therapies

15. Sinusitis Market Drivers

16. Sinusitis Market Barriers

17.  Sinusitis Appendix

18. Sinusitis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Sinusitis treatment, visit @ Sinusitis Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Categories